JPMORGAN CHASE & CO - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AD2. A total of 34 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,650,746
+434.3%
1,688,000
+417.8%
0.00%
Q2 2023$308,960
+1959.7%
326,000
+1937.5%
0.00%
Q1 2023$15,000
-55.9%
16,000
-56.8%
0.00%
Q2 2022$34,00037,0000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 127,800,000$118,341,5222.45%
Boussard & Gavaudan Investment Management LLP 17,500$16,097,1751.78%
BRAIDWELL LP 52,740,000$48,949,3131.64%
WOLVERINE ASSET MANAGEMENT LLC 109,030,000$101,603,4461.05%
Sonora Investment Management Group, LLC 9,195,000$8,531,7560.78%
CSS LLC/IL 11,966,000$11,133,2860.63%
MACKAY SHIELDS LLC 24,332,000$22,563,5420.58%
SSI INVESTMENT MANAGEMENT LLC 6,935,000$6,401,8740.41%
ADVENT CAPITAL MANAGEMENT /DE/ 18,450,000$17,123,9060.30%
Magnetar Financial LLC 16,700,000$15,5100.26%
View complete list of IONIS PHARMACEUTICALS INC shareholders